Skip to content
10-Q

Quarterly Report

Edesa Biotech, Inc. EDSA

0001171843-26-003433

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · May 13, 2026 8.89M sh
Operating Cash Flow Q2 2026 · Mar 31, 2026 −$4.1M
Operating Cash Flow Q2 2026 · Mar 31, 2025 −$3.9M
Cash And Equivalents Q2 2026 · Mar 31, 2026 $10M
Stockholders Equity Q2 2026 · Mar 31, 2026 $10.2M
Stockholders Equity Q2 2026 · Dec 31, 2025 $13.95M
Stockholders Equity Q2 2026 · Sep 30, 2025 $12.45M
Stockholders Equity Q2 2026 · Mar 31, 2025 $15.54M
Stockholders Equity Q2 2026 · Dec 31, 2024 $2.26M
Stockholders Equity Q2 2026 · Sep 30, 2024 $1.98M
Current Liabilities Q2 2026 · Mar 31, 2026 $2.19M
Current Liabilities Q2 2026 · Sep 30, 2025 $1.08M
Current Assets Q2 2026 · Mar 31, 2026 $10.42M
Current Assets Q2 2026 · Sep 30, 2025 $11.51M
Total Assets Q2 2026 · Mar 31, 2026 $12.38M
Total Assets Q2 2026 · Sep 30, 2025 $13.53M
Eps Basic Q2 2026 · Mar 31, 2026 −$0.49
Eps Basic Q2 2026 · Mar 31, 2026 −$0.78
Eps Basic Q2 2026 · Mar 31, 2025 −$0.30
Eps Basic Q2 2026 · Mar 31, 2025 −$0.74
Sga Expense Q2 2026 · Mar 31, 2026 $1.53M
Sga Expense Q2 2026 · Mar 31, 2026 $2.75M
Sga Expense Q2 2026 · Mar 31, 2025 $1.15M
Sga Expense Q2 2026 · Mar 31, 2025 $2.03M
Rd Expense Q2 2026 · Mar 31, 2026 $2.77M
Rd Expense Q2 2026 · Mar 31, 2026 $3.89M
Rd Expense Q2 2026 · Mar 31, 2025 $484.31K
Rd Expense Q2 2026 · Mar 31, 2025 $1.5M
Net Income Q2 2026 · Mar 31, 2026 −$4.22M
Net Income Q2 2026 · Mar 31, 2026 −$6.47M
Net Income Q2 2026 · Mar 31, 2025 −$1.59M
Net Income Q2 2026 · Mar 31, 2025 −$3.21M
Operating Income Q2 2026 · Mar 31, 2026 −$4.3M
Operating Income Q2 2026 · Mar 31, 2026 −$6.64M
Operating Income Q2 2026 · Mar 31, 2025 −$1.64M
Operating Income Q2 2026 · Mar 31, 2025 −$3.54M